Conveners
Tuesday afternoon - Poster Presentations - Screen1
- Oleg Belyakov (IAEA)
Hanae Bakkali
(Institut National d'Oncologie, Rabat)
20/06/2017, 15:30
Clinical Radiation Oncology
Poster
Introduction of the study:
The Freiburg Flap from ELEKTA is a flexible mesh still surface mould for skin or intraoperative surface treatment. The mould can be easily adapted to any shape. It ensures a constant distance of the treatment catheter to the skin of 5mm for reproducible dosimetry, treatment channels are set 10 mm a part from each others. Cutter, flexible implant tubes are introduced...
Mohamed Zaghloul
(Children's Cancer Hospital,Egypt & National Cancer Institute, Cairo University)
20/06/2017, 15:35
Clinical Radiation Oncology
Poster
Background: Pediatric diffuse intrinsic pontine glioma (DIPG) remains for the last decades as a dismal disease though of the rigorous attempts to improve results through adding chemotherapy, immunotherapy or target therapy in different combination, scheduling and intensity to the already established conventional radiation therapy. We previously reported that hypofractionated radiotherapy, in a...
Gourav Kumar Jain
(Department of Radiological Physics, SMS Medical College & Hospital, Jaipur)
20/06/2017, 15:40
Clinical Radiation Oncology
Poster
Purpose
Postoperative radiotherapy significantly reduces the risk of loco-regional failure and improves disease-free survival. However, peripheral dose to the contralatral breast is cause of concern due to its higher radiosensitivity towards radiation induced second malignancy. The present study aimed to measure the contralatral breast dose from the post mastectomy radiotherapy (PMRT) using...
AYA ABAZA
(Assistant Prof. of Safety and Prevention of Oncology at ENRRA)
20/06/2017, 15:45
Clinical Radiation Oncology
Poster
Background: Multiple myeloma (MM) is hematologic malignancy characterized by the accumulation of malignant plasma cells in the bone marrow. Recently, MM remains uniformly fatal with a median survival of approximately 50 months after diagnosis. MM is extremely susceptible to radiation treatment and targeted radiotherapy including bone-seeking radiopharmaceuticals, monoclonal antibodies...
